These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34712681)

  • 1. Levosimendan to Facilitate Weaning From Cardiorespiratory Support in Critically Ill Patients: A Meta-Analysis.
    Luo JC; Zheng WH; Meng C; Zhou H; Xu Y; Tu GW; Luo Z; Huang HB
    Front Med (Lausanne); 2021; 8():741108. PubMed ID: 34712681
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    Liu Y; Zhang L; Yao Y; Li Y; Qin W; Li Y; Xue W; Li P; Chen Y; Chen X; Guo H
    Clin Res Cardiol; 2024 Apr; 113(4):509-521. PubMed ID: 37217802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management and Outcome: A Systematic Review and Meta-Analysis.
    Kaddoura R; Omar AS; Ibrahim MIM; Alkhulaifi A; Lorusso R; Elsherbini H; Soliman O; Caliskan K
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2483-2495. PubMed ID: 33583718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan's effect on venoarterial extracorporeal membrane oxygenation weaning.
    Hau M; Fong KM; Au SY
    Int J Artif Organs; 2022 Jun; 45(6):571-579. PubMed ID: 35570732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.
    Yang B; Zhao T; Guo B; Li Y
    Perfusion; 2023 Mar; 38(2):305-312. PubMed ID: 34689640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of levosimendan on survival and weaning from ECMO after extracorporeal cardiopulmonary resuscitation.
    Gaisendrees C; Schlachtenberger G; Gerfer S; Krasivskyi I; Djordjevic I; Sabashnikov A; Kosmopoulos M; Jaeger D; Luehr M; Kuhn E; Deppe AC; Wahlers T
    Artif Organs; 2023 Aug; 47(8):1351-1360. PubMed ID: 37032531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Chen YW; Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
    Front Cardiovasc Med; 2022; 9():912321. PubMed ID: 35845047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis.
    Burgos LM; Seoane L; Furmento JF; Costabel JP; Diez M; Vrancic M; Aissaoui N; Benzadón MN; Navia D
    Perfusion; 2020 Sep; 35(6):484-491. PubMed ID: 32449494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis.
    Bertini P; Paternoster G; Landoni G; Falcone M; Nocci M; Costanzo D; Brizzi G; Romani M; Esposito A; Guarracino F
    Minerva Cardiol Angiol; 2023 Oct; 71(5):564-574. PubMed ID: 35687316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis.
    Guilherme E; Jacquet-Lagrèze M; Pozzi M; Achana F; Armoiry X; Fellahi JL
    Crit Care; 2020 Jul; 24(1):442. PubMed ID: 32677985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of levosimendan in weaning children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery.
    Pan KC; Shankar S; Millar J; Chiletti R; Butt W; d'Udekem Y; Namachivayam SP
    Eur J Cardiothorac Surg; 2021 Jan; 59(1):262-268. PubMed ID: 32910173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit.
    Vally S; Ferdynus C; Persichini R; Bouchet B; Braunberger E; Lo Pinto H; Martinet O; Vandroux D; Aujoulat T; Allyn J; Allou N
    Ann Intensive Care; 2019 Feb; 9(1):24. PubMed ID: 30707314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.
    Ellouze O; Soudry Faure A; Radhouani M; Abou-Arab O; Besnier E; Moussa M; Cransac A; Ksiazek E; Fischer MO; Mertes PM; Bouhemad B; Guinot PG
    ESC Heart Fail; 2021 Aug; 8(4):3339-3347. PubMed ID: 34145993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan in patients undergoing extracorporeal membrane oxygenation after cardiac surgery: an emulated target trial using observational data.
    Massol J; Simon-Tillaux N; Tohme J; Hariri G; Dureau P; Duceau B; Belin L; Hajage D; De Rycke Y; Charfeddine A; Lebreton G; Combes A; Bouglé A
    Crit Care; 2023 Feb; 27(1):51. PubMed ID: 36750852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children.
    Rose L; Schultz MJ; Cardwell CR; Jouvet P; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009235. PubMed ID: 24915581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: Impact on the success of weaning and survival.
    Alonso-Fernandez-Gatta M; Merchan-Gomez S; Gonzalez-Cebrian M; Diego-Nieto A; Alzola E; Toranzo-Nieto I; Barrio A; Martin-Herrero F; Sanchez PL
    Artif Organs; 2021 Jul; 45(7):717-725. PubMed ID: 33377185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal membrane oxygenation for critically ill adults.
    Tramm R; Ilic D; Davies AR; Pellegrino VA; Romero L; Hodgson C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010381. PubMed ID: 25608845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: current evidence and future directions.
    Sangalli F; Bellani G; Affronti A; Volpi F; Feri M; Marini M; Quacquarelli A; Vitale D; Guarracino F
    Minerva Anestesiol; 2020 Jun; 86(6):645-651. PubMed ID: 32013333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated versus non-automated weaning for reducing the duration of mechanical ventilation for critically ill adults and children.
    Rose L; Schultz MJ; Cardwell CR; Jouvet P; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009235. PubMed ID: 23740737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.